Replimune (REPL) Enterprise Value (2018 - 2026)
Replimune's Enterprise Value came in at $947.39 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with $4.87 million a year earlier and up 29.0% from the prior quarter.
Replimune (REPL) Enterprise Value (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Replimune reported Enterprise Value of $214.03 million; for FY2026 (ended Mar 31, 2026), it was $363.9 million, up 35.9% from FY2025.
- Enterprise Value carries a five-year compound annual growth rate of -17.4% (FY2021 to FY2026).
- Going back by fiscal year, Enterprise Value was $267.77 million in FY2025 (+230.2%), $81.09 million in FY2024 (-80.6%), $417.52 million in FY2023 (+2.3%) and $408.16 million in FY2022 (-56.8%).
- The fiscal Q2 2027 figure represents the highest quarterly Enterprise Value since fiscal Q2 2022.
- Year-over-year, Enterprise Value increased in six of the last seven quarters, with growth averaging 159.8%.
- The fastest year-over-year change in Enterprise Value over five years came in fiscal Q3 2025 (growth of 674.3%), and the weakest in fiscal Q2 2026 (a decline of 98.5%).
- Business Quant data shows REPL's Enterprise Value at $734.32 million (Q1 2027), $363.9 million (Q4 2026) and $504.88 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Replimune | 2.40 Bn | 1.35 Bn | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 947.39 Mn |
| Jun 30, 2026 | 734.32 Mn |
| Mar 31, 2026 | 363.90 Mn |
| Dec 31, 2025 | 504.88 Mn |
| Sep 30, 2025 | 4.87 Mn |
| Jun 30, 2025 | 319.49 Mn |
| Mar 31, 2025 | 267.77 Mn |
| Dec 31, 2024 | 396.04 Mn |
| Sep 30, 2024 | 317.55 Mn |
| Jun 30, 2024 | 145.67 Mn |
| Mar 31, 2024 | 81.09 Mn |
| Dec 31, 2023 | 51.15 Mn |
| Sep 30, 2023 | 513.74 Mn |
| Jun 30, 2023 | 830.33 Mn |
| Mar 31, 2023 | 417.52 Mn |
| Dec 31, 2022 | 924.04 Mn |
| Sep 30, 2022 | 487.18 Mn |
| Jun 30, 2022 | 466.66 Mn |
| Mar 31, 2022 | 408.16 Mn |
| Dec 31, 2021 | 859.12 Mn |
Replimune Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=REPL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();